{"id":"https://openalex.org/W2970297900","doi":"https://doi.org/10.1016/j.nephro.2019.07.207","title":"Traitement par tolvaptan dans la polykystose r\u00e9nale autosomique dominante : aspects pratiques","display_name":"Traitement par tolvaptan dans la polykystose r\u00e9nale autosomique dominante : aspects pratiques","publication_year":2019,"publication_date":"2019-08-26","ids":{"openalex":"https://openalex.org/W2970297900","doi":"https://doi.org/10.1016/j.nephro.2019.07.207","mag":"2970297900"},"language":"fr","primary_location":{"id":"doi:10.1016/j.nephro.2019.07.207","doi":"https://doi.org/10.1016/j.nephro.2019.07.207","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nephro.2019.07.207","pdf_url":null,"source":{"id":"https://openalex.org/S149374293","display_name":"N\u00e9phrologie & Th\u00e9rapeutique","issn_l":"1769-7255","issn":["1769-7255","1872-9177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"N\u00e9phrologie &amp; Th\u00e9rapeutique","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"B. Boisselier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101990","display_name":"Otsuka (France)","ror":"https://ror.org/017f12b13","country_code":"FR","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210101990"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"B. Boisselier","raw_affiliation_strings":["D\u00e9partement M\u00e9dical Otsuka Pharmaceutical France SAS, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement M\u00e9dical Otsuka Pharmaceutical France SAS, Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210101990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107352148","display_name":"Dominique Chauveau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"D. Chauveau","raw_affiliation_strings":["D\u00e9partement de N\u00e9phrologie CHU de Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de N\u00e9phrologie CHU de Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057753461","display_name":"Dominique Guerrot","orcid":"https://orcid.org/0000-0002-5953-5785","observed_orcids":["https://orcid.org/0000-0002-5953-5785","https://orcid.org/0000-0001-9562-530X"]},"institutions":[{"id":"https://openalex.org/I4210154623","display_name":"Centre Hospitalier Universitaire de Rouen","ror":"https://ror.org/04cdk4t75","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210154623"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Guerrot","raw_affiliation_strings":["Service de N\u00e9phrologie, CHU Rouen, Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de N\u00e9phrologie, CHU Rouen, Rouen, France","institution_ids":["https://openalex.org/I4210154623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025976062","display_name":"Bertrand Knebelmann","orcid":"https://orcid.org/0000-0002-8115-7303","observed_orcids":["https://orcid.org/0000-0002-8115-7303"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Knebelmann","raw_affiliation_strings":["Service de N\u00e9phrologie Adultes, AP\u2013HP, H\u00f4pital Universitaire Necker, Universit\u00e9 Paris Descartes, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de N\u00e9phrologie Adultes, AP\u2013HP, H\u00f4pital Universitaire Necker, Universit\u00e9 Paris Descartes, Paris, France","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101828182","display_name":"Yannick Le Meur","orcid":"https://orcid.org/0000-0001-8913-415X","observed_orcids":["https://orcid.org/0000-0001-8913-415X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Le Meur","raw_affiliation_strings":["Service de n\u00e9phrologie, CHU La cavale Blanche, Brest, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de n\u00e9phrologie, CHU La cavale Blanche, Brest, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075309870","display_name":"L. Latreche-Goubaut","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101990","display_name":"Otsuka (France)","ror":"https://ror.org/017f12b13","country_code":"FR","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210101990"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Latreche-Goubaut","raw_affiliation_strings":["D\u00e9partement M\u00e9dical Otsuka Pharmaceutical France SAS, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement M\u00e9dical Otsuka Pharmaceutical France SAS, Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210101990"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5107352148"],"corresponding_institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210101990"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09330195,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"5","first_page":"348","last_page":"348"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11412","display_name":"Genetic and Kidney Cyst Diseases","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11412","display_name":"Genetic and Kidney Cyst Diseases","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tolvaptan","display_name":"tolvaptan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/autosomal-dominant-polycystic-kidney-disease","display_name":"autosomal dominant polycystic kidney disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-initiation","display_name":"treatment initiation","score":0.7289999723434448},{"id":"https://openalex.org/keywords/patient-information","display_name":"patient information","score":0.5479999780654907},{"id":"https://openalex.org/keywords/patient-preparation","display_name":"patient preparation","score":0.6169999837875366},{"id":"https://openalex.org/keywords/patient-support","display_name":"patient support","score":0.5920000076293945},{"id":"https://openalex.org/keywords/expert-consensus","display_name":"expert consensus","score":0.4350000023841858},{"id":"https://openalex.org/keywords/patient-motivation","display_name":"patient motivation","score":0.328000009059906},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.30799999833106995},{"id":"https://openalex.org/keywords/patient-follow-up","display_name":"patient follow-up","score":0.3070000112056732},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6972529292106628},{"id":"https://openalex.org/C2780615674","wikidata":"https://www.wikidata.org/wiki/Q426132","display_name":"Tolvaptan","level":3,"score":0.4601609706878662},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4540891647338867},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1524660885334015},{"id":"https://openalex.org/C2776703092","wikidata":"https://www.wikidata.org/wiki/Q824292","display_name":"Hyponatremia","level":2,"score":0.05588650703430176}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.nephro.2019.07.207","doi":"https://doi.org/10.1016/j.nephro.2019.07.207","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nephro.2019.07.207","pdf_url":null,"source":{"id":"https://openalex.org/S149374293","display_name":"N\u00e9phrologie & Th\u00e9rapeutique","issn_l":"1769-7255","issn":["1769-7255","1872-9177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"N\u00e9phrologie &amp; Th\u00e9rapeutique","raw_type":"journal-article"},{"id":"pmh:oai:HAL:hal-02276506v1","doi":null,"is_oa":false,"landing_page_url":"https://univ-brest.hal.science/hal-02276506","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"N\u00e9phrologie & Th\u00e9rapeutique, 2019, 15 (5)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2754914952","https://openalex.org/W2890725008","https://openalex.org/W2889472590","https://openalex.org/W2289257470","https://openalex.org/W3201263896","https://openalex.org/W7015347263","https://openalex.org/W3022567303","https://openalex.org/W2884670958","https://openalex.org/W3176615872","https://openalex.org/W7043836517"],"abstract_inverted_index":{"Le":[0,77,179,240],"traitement":[1,114,208,218,258],"par":[2,97,122,259],"tolvaptan":[3,57,260],"repr\u00e9sente":[4],"un":[5,84,159,231],"changement":[6],"de":[7,14,22,25,28,48,63,79,93,108,119,161,167,198,201,268,291,294],"paradigme":[8],"dans":[9],"la":[10,15,23,26,196,215,250,292],"prise":[11,49,94],"en":[12,50,95,252],"charge":[13,96],"polykystose":[16],"r\u00e9nale":[17],"autosomique":[18],"dominante":[19],"(PKRAD).":[20],"L\u2019avis":[21],"Commission":[24],"Transparence":[27],"2015":[29],"pr\u00e9cise":[30],"l\u2019AMM":[31],"europ\u00e9enne":[32],"et":[33,62,110,126,133,147,200,209,214,242,254],"d\u00e9taille":[34],"l\u2019\u00e9ligibilit\u00e9":[35],"clinique":[36],"des":[37,59,101,144,181,183,236,244,247,275,298],"patients":[38],"au":[39,74,219],"tolvaptan,":[40],"mais":[41],"ne":[42],"d\u00e9crit":[43],"pas":[44],"les":[45,105,123],"aspects":[46,91,106],"pratiques":[47,92,107,246],"charge.":[51],"Or,":[52],"le":[53,255],"mode":[54],"d\u2019action":[55],"du":[56,68,111,113,128,149,193,207,211,217,257,283],"impose":[58],"modalit\u00e9s":[60],"d\u2019instauration":[61],"suivi":[64,112,256],"sp\u00e9cifiques":[65],":":[66],"information":[67],"patient,":[69],"pr\u00e9paration":[70,202],"aux":[71,87],"inconv\u00e9nients,":[72],"accompagnement":[73],"long":[75,220],"cours.":[76],"but":[78],"notre":[80],"travail":[81,168],"\u00e9tait":[82],"d\u2019\u00e9tablir":[83,172],"guide,":[85],"destin\u00e9":[86],"n\u00e9phrologues,":[88],"reprenant":[89],"ces":[90],"tolvaptan.":[98,150],"Les":[99,223],"questions":[100,137,188],"n\u00e9phrologues":[102,184,248],"fran\u00e7ais":[103],"concernant":[104,249],"l\u2019initiation":[109,204],"ont":[115,138,153,225,261],"\u00e9t\u00e9":[116,139,154],"syst\u00e9matiquement":[117],"r\u00e9pertori\u00e9es":[118],"fa\u00e7on":[120],"anonyme":[121],"r\u00e9f\u00e9rents":[124],"scientifiques":[125],"m\u00e9dicaux":[127],"laboratoire":[129],"Otsuka":[130],"entre":[131],"f\u00e9vrier":[132],"juin":[134],"2018.":[135],"Ces":[136],"soumises":[140],"\u00e0":[141,158,176,234,280],"27":[142],"investigateurs":[143],"\u00e9tudes":[145],"pivots":[146],"observationnelles":[148],"Leurs":[151],"r\u00e9ponses":[152],"collig\u00e9es":[155],"puis":[156],"pr\u00e9sent\u00e9es":[157],"groupe":[160],"4":[162],"experts":[163,224],"lors":[164],"d\u2019une":[165,169],"r\u00e9union":[166],"journ\u00e9e,":[170],"afin":[171],"une":[173],"r\u00e9ponse":[174],"consensuelle":[175],"chaque":[177,281],"question.":[178],"recueil":[180,241],"attentes":[182],"a":[185],"identifi\u00e9":[186],"19":[187,228,269],"simples":[189],"portant":[190],"sur":[191],"l\u2019information":[192],"patient":[194,212],"(3),":[195,205],"phase":[197],"motivation":[199],"avant":[203],"l\u2019instauration":[206],"l\u2019accompagnement":[210],"(8),":[213],"gestion":[216],"cours":[221],"(5).":[222],"ainsi":[226],"propos\u00e9":[227],"r\u00e9ponses,":[229],"constituant":[230],"guide":[232,266],"pratique":[233,267],"l\u2019attention":[235],"prescripteurs":[237],"(Fig.":[238],"1).":[239],"l\u2019analyse":[243],"question":[245],"mise":[251],"place":[253],"permis":[262],"l\u2019\u00e9laboration":[263],"d\u2019un":[264],"premier":[265],"questions-r\u00e9ponses.":[270],"Il":[271,286],"ressort":[272],"qu\u2019une":[273],"compr\u00e9hension":[274],"enjeux":[276],"d\u2019accompagnement":[277],"est":[278],"indispensable":[279],"\u00e9tape":[282],"parcours":[284],"th\u00e9rapeutique.":[285],"sera":[287],"int\u00e9ressant":[288],"d\u2019\u00e9valuer":[289],"l\u2019impact":[290],"diffusion":[293],"cet":[295],"outil":[296],"aupr\u00e8s":[297],"n\u00e9phrologues.":[299]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-09-05T00:00:00"}
